BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32776411)

  • 21. [The clinical value of oral robotic surgery in the treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Yang ZY; Yang AK; Zhang Q; Li QL; Chen SW; Chen JT; Song M
    Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):570-576. PubMed ID: 35754232
    [No Abstract]   [Full Text] [Related]  

  • 22. Transoral robotic surgery for squamous cell carcinoma of the oropharynx in a primarily human papillomavirus-negative patient population.
    Viros Porcuna D; Pollan Guisasola C; Viña Soria C; Cirauqui Cirauqui B; Pardo Muñoz L; Collurá F; Mesia Nin R
    Clin Transl Oncol; 2020 Aug; 22(8):1303-1311. PubMed ID: 31858433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
    Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Lörincz BB; Möckelmann N; Busch CJ; Knecht R
    Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes.
    Moore EJ; Van Abel KM; Price DL; Lohse CM; Olsen KD; Jackson RS; Martin EJ
    Head Neck; 2018 Apr; 40(4):747-755. PubMed ID: 29327784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvage transoral robotic surgery in early-stage oropharyngeal recurrence.
    Asairinachan A; O'Duffy F; Fua T; Magarey MJR; Dixon BJ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jul; 132(1):18-25. PubMed ID: 33744203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of the Eighth Edition American Joint Committee on Cancer Staging System for HPV-Related Oropharyngeal Cancer Treated With Transoral Robotic Surgery.
    Badhey AK; Olson A; Kadakia S; Russo J; Ting P; Khalid M; Yao M; Teng MS; Genden EM; Miles BA; Chai RL
    Laryngoscope; 2018 May; 128(5):1133-1139. PubMed ID: 28990700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma.
    Sload R; Silver N; Jawad BA; Gross ND
    Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapy.
    Carey RM; Shimunov D; Weinstein GS; Cannady SB; Lukens JN; Lin A; Swisher-McClure S; Bauml JM; Aggarwal C; Cohen RB; Newman JG; Chalian AA; Rassekh CH; Basu D; O'Malley BW; Rajasekaran K; Brody RM
    Head Neck; 2021 Apr; 43(4):1128-1141. PubMed ID: 33325579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncological outcome following initiation of treatment for stage III and IV HPV negative oropharyngeal cancers with transoral robotic surgery (TORS).
    Dabas S; Gupta K; Sharma AK; Shukla H; Ranjan R; Sharma DK
    Eur J Surg Oncol; 2019 Nov; 45(11):2137-2142. PubMed ID: 31239156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond.
    Van Abel KM; Quick MH; Graner DE; Lohse CM; Price DL; Price KAR; Ma DJ; Moore EJ
    Am J Otolaryngol; 2019; 40(5):729-734. PubMed ID: 31303455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV; Schiff BA; Garg M; Haigentz M
    Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal Cancer.
    Sher DJ; Fidler MJ; Tishler RB; Stenson K; al-Khudari S
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):512-22. PubMed ID: 26867880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery.
    Yver CM; Shimunov D; Weinstein GS; Rajasekaran K; Cannady SB; Lukens JN; Lin A; Swisher-McClure S; Cohen RB; Aggarwal C; Bauml JM; Loevner LA; Newman JG; Chalian AA; Rassekh CH; Basu D; O'Malley BW; Brody RM
    Oral Oncol; 2021 Jul; 118():105307. PubMed ID: 33932874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer.
    Dave E; Ozbek U; Gupta V; Genden E; Miles B; Teng M; Posner M; Misiukiewicz K; Bakst RL
    PLoS One; 2017; 12(7):e0181108. PubMed ID: 28732044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of surgery and salvage surgery in the era of HPV-associated oropharyngeal carcinomas].
    Hussain T; Mattheis S; Lang S
    HNO; 2020 Sep; 68(9):688-694. PubMed ID: 32638060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid Usage and Prescribing Predictors Following Transoral Robotic Surgery for Oropharyngeal Cancer.
    Abt NB; Holcomb AJ; Feng AL; Suresh K; Mokhtari TE; McHugh CI; Parikh AS; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
    Laryngoscope; 2021 Jun; 131(6):E1888-E1894. PubMed ID: 33210756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
    Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
    JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.